|
|
||||||||
J Thorac Cardiovasc Surg 2000;119:1102-1109
© 2000 The American Association for Thoracic Surgery
SURGERY FOR CONGENITAL HEART DISEASE |
From the Institute for Biodiagnostics, National Research Council of Canadaa; Medical Systems, General Electronic,b Milwaukee, Wis; and the Department of Cardiovascular Surgery, University of Manitoba, Winnipeg,c Manitoba, Canada.
This work was supported by the Medical Research Council of Canada (grant 9609OP-348-BME-CDAA-26321) and the Heart and Stroke Foundation of Manitoba.
Address for reprints: Ganghong Tian, 435 Ellice Ave, Winnipeg, Manitoba, Canada, R3B 1Y6 (E-mail: tian{at}ibd.nrc.ca ).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Retrograde perfusion of cardioplegic solution through the coronary sinus has been proven to be an effective technique for myocardial protection in adult hearts, especially during aortic valve operations and coronary artery bypass grafting.
7-11 However, it has not been demonstrated whether this technique can provide adequate myocardial protection for neonatal and infant hearts. Because the venous system in immature myocardium may not develop as well as in mature myocardium, the efficacy of retrograde cardioplegia observed in adult hearts may not be seen in neonatal and infant hearts. The purpose of this study was to assess the effects of retrograde cardioplegia on myocardial perfusion and energy metabolism in immature hearts. Magnetic resonance (MR) imaging in combination with MR contrast agents was used to characterize the myocardial perfusion of retrograde cardioplegia. The ability of retrograde cardioplegia to sustain myocardial energy metabolism was studied by using phosphorous 31 (31P) MR spectroscopy. Antegrade cardioplegia was used as the control technique.
| Material and methods |
|---|
|
|
|---|
Eighteen domestic piglets aged 5 to 11 days and weighing 3.0 to 4.5 kg were sedated with an intramuscular administration of midazolam (0.3 mg/kg body weight) and ketamine (20 mg/kg body weight). Anesthesia was maintained with 1% to 2% isoflurane in a mixture of oxygen and nitrous oxide. The respiratory rate and volume were adjusted to keep the arterial blood gases within the normal physiologic range. A sternotomy was performed along the midline. Anticoagulation was provided by the injection of heparin (2000 IU) into the superior vena cava. Heparinized cold (~4°C) cardioplegic solution was infused into the aortic root (20 mL/kg body weight). The hearts were then excised and mounted on a Langendorff apparatus. A retrograde catheter with a manually inflated balloon at the tip (6F; Medtronic of Canada Ltd, Mississauga, Ontario) was positioned into the coronary sinus in the hearts subjected to retrograde cardioplegia. The position of the catheter was adjusted so that the external edge of the balloon was at the orifice of the coronary sinus. The hemiazygos vein was ligated. The Langendorff system was then placed in the center of the magnet. The temperature of the hearts was maintained at 36.5°C ± 0.5°C throughout the protocol. An in-line transonic flowmeter was used for monitoring the cardioplegic delivery rate.
Experimental groups
Piglet hearts were divided into 3 groups. The hearts in group 1 (n = 6) were used to assess the myocardial perfusion of antegrade cardioplegia and retrograde cardioplegia with MR perfusion imaging. All 6 hearts in this group were subjected to antegrade cardioplegia and retrograde cardioplegia at similar perfusion pressures (30-40 mm Hg) in a random order. An extracellular-type MR contrast agent (gadolinium diethylenetriamine pentaacetic acid [Gd-DTPA]; Berlex, Montreal, Quebec, Canada) was injected into the cardioplegic lines during antegrade cardioplegia and retrograde cardioplegia, respectively. The distribution of the contrast agent across myocardium was monitored with T1-weighted MR imaging. The perfusion medium containing the contrast agents was not recirculated, so that MR contrast agent injected during antegrade cardioplegia would have no effect on the subsequent retrograde cardioplegia. Complete washout of the contrast agent was also confirmed with MR imaging before subsequent contrast injection.
The piglet hearts in groups 2 and 3 were subjected to a protocol consisting of 30 minutes of control perfusion, 45 minutes of cardioplegic arrest, and 30 minutes of reperfusion. In the retrograde group (n = 6), cardioplegic arrest was induced with 2-minute antegrade cardioplegia and maintained with 43-minute normothermic (36.5°C ± 0.5°C) retrograde cardioplegia (group 2, n = 6). The hearts in group 3 (n = 6) were subjected to 45 minutes of continuous normothermic antegrade cardioplegia and used as controls. All piglets used in this study had different mothers, and they were assigned to the groups randomly. Myocardial energy metabolism and intracellular pH (pHi) were monitored throughout the protocol by 31P MR spectroscopy. Myocardial contractile function was assessed during control perfusion and reperfusion periods.
Perfusion media
Because the amount of blood obtained from a piglet was not sufficient to prime the Langendorff system, the piglet hearts in this study were perfused with modified Krebs-Henseleit solution. During cardiac arrest, the piglet hearts were perfused with hyperkalemic Krebs-Henseleit solution containing 100 mmol/L NaCl, 16 mmol/L KCl, 16 mmol/L MgCl2, 0.5 mmol/L ethylenediamine tetraacetic acid, 11 mmol/L glucose, 25 mmol/L NaHCO3, 1.75 mmol/L CaCl2, 1.2 mmol/L KH2PO4, and 0.5% bovine serum albumin (Sigma Chemical Co, St Louis, Mo). During the control and reperfusion periods (for groups 2 and 3), the piglet hearts were perfused with normokalemic Krebs-Henseleit solution containing 118 mmol/L NaCl, 3.5 mmol/L KCl, 1.2 mmol/L MgSO4, 0.5 mmol/L ethylenediamine tetraacetic acid, 11 mmol/L glucose, 25 mmol/L NaHCO3, 1.75 mmol/L CaCl2, 1.2 mmol/L KH2PO4, and 0.5% bovine serum albumin. Both perfusion media were oxygenated with 95% oxygen and 5% carbon dioxide to maintain its oxygen tension between 550 and 600 mm Hg and pH at 7.35 to 7.45. Perfusion pressure was controlled at 30 to 40 mm Hg during cardiac arrest (retrograde cardioplegia and antegrade cardioplegia) and 70 to 80 mm Hg during heart-beating periods, respectively.
Assessment of myocardial perfusion
Distribution of retrograde and antegrade cardioplegic solutions was determined by using T1-weighted MR imaging with Gd-DTPA. During retrograde cardioplegia and antegrade cardioplegia, 0.5 mmol of Gd-DTPA was injected as a bolus into the perfusion line. During its first pass, the Gd-DTPAinduced T1 signal changes were measured by means of continuous acquisition of 200 T1-weighted images. Because Gd-DTPA increases the T1 signal intensities of the myocardium, bright areas in T1 images indicate the regions of perfused myocardium, whereas dark areas reveal nonperfused myocardium.
T1-weighted imaging was performed in a 7-T, 40-cm horizontal bore magnet equipped with a Biospec spectrometer (Bruker Inc, Karlsruhe, Germany) and a Helmholtz probe surrounding the whole heart. T1-weighted images were acquired by means of an inversion-recovery Turbo-FLASH sequence with a 3.6-ms echo time and a 6.4-ms repetition time. Each image covered a 12 x 12 cm2 field of view with a 128 x 128 matrix, leading to a pixel size of 0.93 x 0.93 mm2. All images were acquired from a 3-mm slice parallel to the short cardiac axis.
Study of the effects of retrograde cardioplegia and antegrade cardioplegia on myocardial energy metabolism
The effects of retrograde cardioplegia and antegrade cardioplegia on myocardial energy metabolism were studied in groups 2 and 3 by monitoring the levels of myocardial phosphocreatine (PCr), inorganic phosphate (Pi), adenosine triphosphate (ATP), and pHi by using 31P MR spectroscopy. 31P spectroscopy was performed on the magnet mentioned above, with a Helmholtz coil surrounding the whole heart.
Free induction decay signals were obtained by using 2048 data points, a 75-microsecond pulse length, and a 2.0-second repetition time. One hundred fifty free induction decay signals were accumulated for each spectrum over a 5-minute period. Intracellular pH was calculated from the chemical shift of the Pi peak relative to that of PCr.
12,13 The ß-peak of ATP was used for its quantification.
Assessment of contractile function
A latex balloon with its volume larger than that of the left ventricle (LV) was placed inside the LV to assess myocardial function of the hearts in groups 2 and 3. Myocardial contractile function was evaluated by measuring LV developed pressure (LVDP) and the maximal rate of LV pressure increase and decrease (±dp/dt). Contractile function was also evaluated by calculating the product of LVDP and heart rate to give the rate pressure product, an index of contractile work. Diastolic pressure of the LV was set at 0 to 5 mm Hg during early period of control perfusion by inflating intraventricular balloon with water. The balloon volume achieved at the diastolic pressure was then kept unchanged throughout protocol.
Statistical analysis
Data are presented as means ± SD. Statistical analyses were performed by using a statistical software STATISTICA (StatSoft, Inc, Tulsa, Okla). Comparisons of energy metabolites, pHi, and cardiac contractile function between groups 2 and 3 were performed by analysis of variance with repeated measures. Significant changes in energy metabolites, pHi, and contractile function that occurred throughout protocol within a group of animals were determined by analysis of variance.
| Results |
|---|
|
|
|---|
|
Effect of retrograde cardioplegia and antegrade cardioplegia on myocardial energy metabolism
The changes in PCr, Pi, ATP, and pHi during retrograde cardioplegia and antegrade cardioplegia are shown in Figs 2 and 3. Retrograde cardioplegia resulted in a statistically significant (P < .05) decrease in PCr and an increase in Pi levels. At the end of retrograde cardioplegia, the level of PCr was 53.5% ± 27.3% of its control value obtained during control perfusion. Corresponding to the changes in PCr and Pi, the hearts in the retrograde cardioplegia group showed a gradual decrease in pHi (Fig 3
, bottom panel ). Intracellular pH at the end of 43 minutes of retrograde cardioplegia (6.83 ± 0.17 pH units) was significantly lower than the control value (7.14 ± 0.10 pH units) measured during control perfusion. These metabolic indices returned to normal soon after reperfusion. Retrograde cardioplegia did not result in any decline in ATP level (Fig 3
, top panel ). This suggests that the energy imbalance caused by retrograde cardioplegia was relatively mild. In contrast, antegrade cardioplegia resulted in a small but significant increase in PCr and a decrease in the Pi level. This suggests that antegrade cardioplegia at a perfusion pressure of 30 to 40 mm Hg provides more than enough flow to sustain normal myocardial energy metabolism.
|
|
|
| Discussion |
|---|
|
|
|---|
During retrograde cardioplegia, T1-weighted images showed dark regions in the RV free walls of 4 of the 6 hearts (Fig 1
, middle panel ), indicating a lack of uniform delivery of cardioplegic solution to the RV free wall in some immature hearts. It has been suggested that the inability of retrograde cardioplegia to perfuse the RV myocardium is related to the diversion of cardioplegic solution from the venulae and capillaries by the thebesian vessels.
17-20 This suggestion is made on the basis of the findings that under physiologic conditions the thebesian vessels help drain a considerable amount of venous blood into the RV chamber.
17 The time course of T1 signal intensities obtained during retrograde cardioplegia did not show any transient increase of T1 signal in the RV wall (data not presented), suggesting that no contrast agent reached the RV wall. Therefore, the inability of retrograde cardioplegia to protect the RV wall is not due to thebesian drainage. We believe that blockage of the ostia of the coronary veins by the retrograde balloon and opening of the coronary veins directly to the right atrium are responsible for the lack of perfusion of the RV during retrograde cardioplegia.
21,22 Two hearts in this group showed similar increases in T1 signal intensities in the RV (38.6 ± 15.3 AU) and LV (42.3 ± 37.15 AU) walls during retrograde cardioplegia, indicating that the ability of retrograde cardioplegia to protect the RV myocardium may depend on the individual heart because of the variation in coronary venous anatomy.
To assess the metabolic effects of retrograde cardioplegia, 31P MR spectroscopy was used to follow myocardial energy metabolism. We found that 43 minutes of normothermic retrograde cardioplegia resulted in a decrease in PCr and pHi and an increase in Pi, suggesting that the level of myocardial perfusion provided by retrograde cardioplegia was less than that required to sustain myocardial energy metabolism under normothermic conditions.
On the basis of the levels of high-energy phosphates, reversible myocardial ischemia can be arbitrarily divided into 3 stages: latency, survival time, and revival time.
4 During the first period of ischemia, there are essentially no changes in the levels of ATP, PCr, or Pi. Oxidative phosphorylation is still the major energy source for maintenance of myocardial homeostasis. During the second phase of ischemia (survival time), PCr is used to replenish ATP stores in the cytoplasm, which leads to a decrease in PCr level accompanied by a rise in Pi. This period ends when the PCr level decreases to approximately 40% of its normal value. In the present study 43 minutes of normothermic retrograde cardioplegia resulted in a decrease in PCr only to 53.5% ± 27.3% of its control level. In addition, the final pHi at the end of 43 minutes of retrograde cardioplegia (6.83 ± 0.17) was also significantly higher than the level (pHi = 6.2 pH unit) considered indicative of severe ischemic injury. Therefore, the levels of both PCr and pHi suggest that ischemic changes during retrograde cardioplegia were very mild. Moreover, complete recovery of energy metabolism and contractile function during reperfusion further demonstrated that the retrograde cardioplegiaassociated ischemic changes observed in this study were not severe. Nevertheless, the reduction in PCr and pHi is negative in regard to myocardial protection, particularly if the ischemic time is prolonged.
Because the piglet hearts used in this study were relatively small, it was not practical to use two surface coils to monitor myocardial energy metabolism in both ventricular walls separately. The present 31P spectroscopy study used a coil surrounding the whole heart. The observed changes in energy metabolism and intracellular pH during retrograde cardioplegia and antegrade cardioplegia reflected the effects of the cardioplegic techniques on both ventricular walls. Because RV perfusion with retrograde cardioplegia was poor in most hearts, it is possible that the actual imbalance in energy metabolites and intracellular pH in the LV wall was less than that observed in the whole heart.
In this study the piglet hearts were perfused with modified Krebs-Henseleit solution, which is probably the major limitation of the present study. It has been demonstrated that blood-based cardioplegia offers several important advantages relative to crystalloid cardioplegia, including its higher oxygen-carrying capacity, higher buffer capacity, more appropriate osmotic load, endogenous oxygen-derived free radical scavengers, and the rheologic effects of red blood cells.
23-25 The latter have been suggested to play an important role in the microcirculation.
24,25 The effects of retrograde cardioplegia on myocardial perfusion and energy metabolism may have been improved if blood cardioplegia had been used in this study.
In addition, it should be mentioned that congenital heart defects in neonates and infants may be associated with pathologic changes in the RV, such as RV hypertrophy and pulmonary hypertension. These pathologic changes may compromise the efficacy of retrograde cardioplegia. Therefore, extrapolation of the results of this study into clinical situations should be done with caution.
In summary, under similar perfusion pressures, myocardial perfusion provided by retrograde cardioplegia is slightly less than that needed to sustain normal myocardial energy under normothermic conditions; however, it is sufficient for complete metabolic and functional recovery. The ability of retrograde cardioplegia to perfuse the RV myocardium is poor and varies between individuals.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. Doenst, H. Bugger, M. Schwarzer, G. Faerber, M. A. Borger, and F. W. Mohr Three good reasons for heart surgeons to understand cardiac metabolism Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 862 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Doenst, C. Schlensak, and F. Beyersdorf Cardioplegia in pediatric cardiac surgery: do we believe in magic? Ann. Thorac. Surg., May 1, 2003; 75(5): 1668 - 1677. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |